Literature DB >> 15184898

The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer.

Steven M Lipkin1, Laura S Rozek, Gad Rennert, Wei Yang, Peng-Chieh Chen, Joseph Hacia, Nathan Hunt, Brian Shin, Steve Fodor, Mark Kokoris, Joel K Greenson, Eric Fearon, Henry Lynch, Francis Collins, Stephen B Gruber.   

Abstract

Most susceptibility to colorectal cancer (CRC) is not accounted for by known risk factors. Because MLH1, MSH2 and MSH6 mutations underlie high-penetrance CRC susceptibility in hereditary nonpolyposis colon cancer (HNPCC), we hypothesized that attenuated alleles might also underlie susceptibility to sporadic CRC. We looked for gene variants associated with HNPCC in Israeli probands with familial CRC unstratified with respect to the microsatellite instability (MSI) phenotype. Association studies identified a new MLH1 variant (415G-->C, resulting in the amino acid substitution D132H) in approximately 1.3% of Israeli individuals with CRC self-described as Jewish, Christian and Muslim. MLH1 415C confers clinically significant susceptibility to CRC. In contrast to classic HNPCC, CRCs associated with MLH1 415C usually do not have the MSI defect, which is important for clinical mutation screening. Structural and functional analyses showed that the normal ATPase function of MLH1 is attenuated, but not eliminated, by the MLH1 415G-->C mutation. The new MLH1 variant confers a high risk of CRC and identifies a previously unrecognized mechanism in microsatellite-stable tumors. These studies suggest that variants of mismatch repair proteins with attenuated function may account for a higher proportion of susceptibility to sporadic microsatellite-stable CRC than previously assumed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184898     DOI: 10.1038/ng1374

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  30 in total

Review 1.  Microsatellite instability in colorectal cancer.

Authors:  C Richard Boland; Ajay Goel
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

Review 2.  The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside.

Authors:  C Richard Boland; Minoru Koi; Dong K Chang; John M Carethers
Journal:  Fam Cancer       Date:  2007-07-17       Impact factor: 2.375

Review 3.  Application of molecular diagnostics for the detection of Lynch syndrome.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Expert Rev Mol Diagn       Date:  2010-07       Impact factor: 5.225

Review 4.  Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term.

Authors:  Jeremy R Jass
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

5.  A promoter polymorphism in the hMLH1 gene (-93G/A) associated with sporadic colorectal cancer.

Authors:  Li-Li Zhang; Xue-Jun Tang; Xiao-Yun Wang; Ying-Wei Zhu; Xiao-Bin Peng; Lei Gong
Journal:  Oncol Lett       Date:  2016-09-26       Impact factor: 2.967

Review 6.  Evolution of the nomenclature for the hereditary colorectal cancer syndromes.

Authors:  C Richard Boland
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 7.  The incidence of Lynch syndrome.

Authors:  Albert de la Chapelle
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 8.  Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome.

Authors:  Linnea M Baudhuin; Lawrence J Burgart; Olga Leontovich; Stephen N Thibodeau
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 9.  DNA mismatch repair and Lynch syndrome.

Authors:  Guido Plotz; Stefan Zeuzem; Jochen Raedle
Journal:  J Mol Histol       Date:  2006-07-04       Impact factor: 2.611

10.  Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases.

Authors:  James Mueller; Isabella Gazzoli; Prathap Bandipalliam; Judy E Garber; Sapna Syngal; Richard D Kolodner
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.